Advertisement

Inpharma Weekly

, Volume 1562, Issue 1, pp 16–16 | Cite as

Erlotinib effective against GEJ, but not gastric, cancers

Clinical study
  • 4 Downloads

Keywords

Gastric Cancer Adenocarcinoma Partial Response Erlotinib Objective Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2006

Personalised recommendations